Beltaven® venom allergy immunotherapy study
Part of Immune system & allergy clinical trials.
This study tests a treatment called Beltaven® for people with severe allergic reactions to bee, wasp, or hornet stings. It aims to see if the treatment is safe and helps prevent future reactions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 14 years or older.
- You have had a serious allergic reaction to a bee, wasp, or hornet sting that affected multiple body systems or just the skin.
- You have tested positive for the allergy with a skin test and a blood test.
- You are willing to receive the allergy shots (immunotherapy) with Beltaven®.
- You are not pregnant, planning pregnancy, or breastfeeding during the study.
- You have not had any venom allergy treatment in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether having strong reactions to a specific bee venom protein can make venom immunotherapy less effective. It may help doctors better predict who is at higher risk for therapy failure after bee stings.
This study monitors the safety of venom immunotherapy (allergy shots) for people with bee or wasp sting allergies. If you are starting this treatment, researchers will track how well you tolerate it over time.
This trial tests a venom immunotherapy for people allergic to bee or wasp stings. It aims to see how well the treatment works in everyday medical practice.
This study looks at how beekeepers develop tolerance to bee venom over time, comparing people who are new to beekeeping, experienced beekeepers without allergies, and beekeepers who have had a recent allergic reaction. If you fall into one of these groups, you may be able to join and help researchers understand how the immune system adapts to bee stings.
This study tests if virtual reality experiences can affect the immune system in people with bee or wasp venom allergies. It may help understand new ways to treat allergies.
This study looks at whether a BAT (a blood test) can stand in for sting/venom “challenges” for people already receiving venom immunotherapy. If it works, it could help patients avoid more risky or uncomfortable challenge procedures while still checking whether treatment is working.
Hear when a new Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.